1 / 3

Supplementary information Figure S1

Supplementary information Figure S1. MDA-MB-231. ANXA1-ASO - - - - + + + + TNF- α (10ng/ml) 0 15 30 60 0 15 30 60 (min). ANXA1. -actin. 1 2 3 4 5 6 7 8. MDA-MB-231.

clancy
Download Presentation

Supplementary information Figure S1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary information Figure S1 MDA-MB-231 ANXA1-ASO - - - - + + + + TNF-α (10ng/ml) 0 15 30 60 0 15 30 60 (min) ANXA1 -actin 1 2 3 4 5 6 7 8 MDA-MB-231 siRNA-ANXA1 Parental Scrambled ANXA1 -actin 1 2 3 A MCF7-V5 MCF7-EV B C ANXA1 Supplementary figure S1. (a) mRNA, protein and (b) cell surface expression of ANXA1 after transfection with V5 expression plasmid. In MCF-7 cells (C) Migration of parental breast cancer cell lines (d) Protein expression of ANXA1 after siRNA and (e) ASO treatment. GAPDH Parental Mock ANXA1-V5 4 5 MCF7-parental MCF7-EV MCF7-V5 ANXA1-V5 ANXA1 Tubulin 1 2 3 D E

  2. Supplementary information Figure S2 1 5 6 7 8 9 10 1112 Fraction p100 MDA-231 p52 p100 MCF7-V5 p52 1 5 6 7 8 9 10 11 12 Fraction p100 MCF7-EV 75 p52 MDA-231 TAK1 48 1 5 6 7 8 9 10 11 12 Fraction IKKβ MDA-231 75 MCF7-V5 TAK1 48 IKKβ MCF7-V5 75 MCF7-EV TAK1 48 IKKβ MCF7-V5 MCF7-EV CXCL12 (100ng/ml) 0 15 30 60 - (min) p65:p50 CXCL12 (100ng/ml) 0 15 30 60 - (min) TNF (10ng/ml) - - - - 30 (min) ANXA1- ASO + + + + + p65:p50 1 2 3 4 5 A B Supplementary figure S2. (A-D) Analysis of gel filtration chromatography analysis of IKK, TRADD, TAK1 and p100/p52. (E) EMSA blots for NF-kB activity. C D E

  3. Supplementary information Figure S3 Supplementary figure S3 (A) Nu/nu athymic mice were injected s.c with MCF7 cells (empty vector) or ANXA1 overexpression vector and monitored over 40 days. Tumor volume was calculated as (length x width x width)/2. (B) MMTV-PyMT mice were crossed to ANXA1 -/- to obtain PyMT ANXA1 +/- and -/- mice. No significant difference was observed in the % of mice with palpable tumors as well as tumor onset. PyMT ANXA1 +/- PyMT ANXA1 -/-

More Related